Latest Sirolimus Stories
Whitehead Institute researchers have linked hyperactivity in the mechanistic target of rapamycin complex 1 (mTORC1) cellular pathway, to reduced ketone production, which is a well-defined physiological trait of aging in mice.
Today Insightra Medical, one of the fastest growing medical device companies announced the expansion of cardiology products by the addition of a line of Coronary Dilatation Balloons (CDB). Irvine, CA (PRWEB) December 12, 2010 Insightra Medical, Irvine, CA, is aggressively targeting three major sectors of the medical device market: Cardiovascular, General Surgery and Urogynecology.
EAST HANOVER, N.J., Dec.
HONG KONG, Dec.
DURHAM, N.C., Nov. 29, 2010 /PRNewswire/ -- Micell Technologies,(TM) Inc.
HONG KONG, Nov.
NEW YORK, Nov. 19, 2010 /PRNewswire-FirstCall/ -- Pfizer Inc.
EAST HANOVER, N.J., Nov.
SILVER SPRING, Md., Oct. 30 /PRNewswire/ -- The Tuberous Sclerosis Alliance (TS Alliance) today announced the first drug approved for a tuberous sclerosis complex (TSC) indication by the Federal Drug Administration (FDA).
EAST HANOVER, N.J., Oct. 29 /PRNewswire/ -- Novartis Pharmaceuticals Corporation ("Novartis") announced today that the U.S.